Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer-Reference-Cited by-同舟云学术

Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer

Published:2002-09-19 Issue:2 Volume:53 Page:109-117
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Gulley James,Chen Alice P.,Dahut William,Arlen Philip M.,Bastian Anne,Steinberg Seth M.,Tsang Kwong,Panicali Dennis,Poole Diane,Schlom Jeffrey,Michael Hamilton J.

Publisher

Wiley

Subject

Urology,Oncology

Reference24 articles.

1. Cancer Statistics, 2002

2. In Vitro Generation of Human Cytotoxic T Lymphocytes Specific for Peptides Derived From Prostate-Specific Antigen

3. Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytes

4. Recombinant poxvirus vaccines. In: editor. Biologic therapy of cancer: principles and practices. 3rd ed. Philadelphia: JB Lippincott Co; 2000. p 686-694.

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of Personalized Dendritic Cell-Based Immunohybridoma Vaccines to Treat Prostate Cancer;Life;2023-07-01

2. Co-transient expression of PSA-Fc and PAP-Fc fusion protein in plant as prostate cancer vaccine candidates and immune responses in mice;Plant Cell Reports;2023-06-03

3. Vaccines as treatments for prostate cancer;Nature Reviews Urology;2023-03-06

4. Co-transient expression of PSA and PAP-Fc fusion proteins as prostate cancer vaccine candidates in plant and immune responses in mice;2023-02-21

5. Oncolyic Virotherapy for Prostate Cancer: Lighting a Fire in Winter;International Journal of Molecular Sciences;2022-10-21